DMII Signs Definitive Financing Deal, Issues $300,000 Interim Convertible Note
Drugs Made In America Acquisition II Corp. entered into a definitive agreement with Alpha Multi Family Office for a contemplated $1,400,000 convertible notes financing, following a $150,000 bridge loan issued March 11, 2026. The company also issued a $300,000 interim convertible note on March 30, 2026, which is a direct financial obligation and can convert into shares of the combined company after a business combination at a 35% discount to market.
Key points
- Definitive Investment and Sponsor Transition Agreement effective March 24, 2026, for a contemplated $1,400,000 convertible notes financing
- Interim Convertible Note of $300,000 issued March 30, 2026, with a maturity of nine months and no interest
- Note converts after the initial business combination at a 35% discount to market price, at the investor's option
- Proceeds to fund accounting, audit and other expenses related to the business combination
The filing
Written by AI on Nov 9, 2026, 11:46 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 03, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.